Stabilized composition for the treatment of psoriasis

Refers to a pharmaceutical formulation comprising: (a) VITAMIN D COMPOUND AS CALCIPOTRIENE present at a concentration of 0.005 wt% (b) Corticosteroids SELECTED Clobetasol Propionate and betamethasone dipropionate present in a concentration of from 0.05 to 0.064% BY WEIGHT RESPECTIVELY (c) N, N-di (C1-C8) substituted alkylamino, carboxylic alkyl (C4-C18) -CARBOXILICOL (C2-C18) AS dodecyl 2- (N, N-dimethylamino) -propionate (DDAIP) A cONCENTRATION OF 1% BY WEIGHT IN A CARRIER white petrolatum and optionally containing MINERAL OIL at a concentration of 3% by weight, tocopherol at a concentration of 0.0002% by weight. ALSO it REFERS Formulating a non-aqueous UNGUENTO STABLE STORAGE useful in the treatment of psoriasis